Results
|
4441.
|
Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. [electronic resource] by
- Herrem, Christopher J
- Tatsumi, Tomohide
- Olson, Kathleen S
- Shirai, Keisuke
- Finke, James H
- Bukowski, Ronald M
- Zhou, Ming
- Richmond, Amy L
- Derweesh, Ithaar
- Kinch, Michael S
- Storkus, Walter J
Producer: 20050628
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
4442.
|
|
|
4443.
|
|
|
4444.
|
|
|
4445.
|
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. [electronic resource] by
- Mozzetti, Simona
- Ferlini, Cristiano
- Concolino, Paola
- Filippetti, Flavia
- Raspaglio, Giuseppina
- Prislei, Silvia
- Gallo, Daniela
- Martinelli, Enrica
- Ranelletti, Franco Oreste
- Ferrandina, Gabriella
- Scambia, Giovanni
Producer: 20050628
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
4446.
|
|
|
4447.
|
|
|
4448.
|
|
|
4449.
|
Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. [electronic resource] by
- Watanabe, Hideaki
- Mamelak, Adam J
- Weiss, Elliot
- Wang, Binghe
- Freed, Irwin
- Brice, Angela K
- Wachtman, Lynn
- Gabrielson, Kathleen L
- Yokota, Naoko
- Hicklin, Daniel J
- Kerbel, Robert S
- Haas, Mark
- Sauder, Daniel N
Producer: 20050628
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
4450.
|
|
|
4451.
|
|
|
4452.
|
|
|
4453.
|
|
|
4454.
|
|
|
4455.
|
|
|
4456.
|
|
|
4457.
|
|
|
4458.
|
|
|
4459.
|
|
|
4460.
|
|